News Author: Erilyn Riley Publish date: December 14, 2016
© Todd Buchanan 2016
SAN DIEGO—Daratumumab added to standard of care regimens drives deep clinical responses beyond complete response (CR), a magni...
News Author: Erilyn Riley Publish date: December 13, 2016
Photo courtesy of ASH
SAN DIEGO—The first-in-class humanized anti-P-selectin antibody SelG1, also known as crizanlizumab, significantly reduced sic...
News Author: Erilyn Riley Publish date: December 11, 2016
2016 ASH Annual Meeting
SAN DIEGO—Ibrutinib, a Bruton’s tyrosine kinase inhibitor approved to treat chronic lymphocytic leukemia and other hematolo...
News Author: Erilyn Riley Publish date: December 9, 2016
SAN DIEGO—The JAK2/FLT3 inhibitor pacritinib significantly reduces spleen volume and symptoms in patients with myelofibrosis and low platelet counts,
...
News Author: Erilyn Riley Publish date: December 7, 2016
SAN DIEGO—Researchers say they have optimized the SPK-9001 adeno-associated viral (AAV) vector
so that a “simple infusion” has significantly reduced ...
News Author: Erilyn Riley Publish date: December 5, 2016
Convention Center, site of
the 2016 ASH Annual Meeting
SAN DIEGO—Results of a phase 1 study suggest that SCD-101, a botanical extract based on an ...
News Author: Erilyn Riley Publish date: November 4, 2016
NEW YORK—Combining 2 technologies—flow cytometry and high-throughput sequencing (HTS)—produces a very sensitive approach to detectin...
News Author: Erilyn Riley Publish date: October 31, 2016
NEW YORK—As the number of therapeutic options for multiple myeloma (MM) increases, so too does the need to reassess prognostic markers for the disease...
News Author: Erilyn Riley Publish date: October 27, 2016
Photo courtesy of the National Institute of General Medical Science NEW YORK—Research has shown that family history is a strong risk factor for dev...
News Author: Erilyn Riley Publish date: October 25, 2016
NEW YORK—Whole-genome sequencing has changed the entire approach to drug development for Waldenström’s macroglobulinemia (WM), accord...
News Author: Erilyn Riley Publish date: October 22, 2016
NEW YORK—It’s important to use the best possible regimen as soon as possible when treating patients with multiple myeloma (MM), according to a speaker...
News Author: Erilyn Riley Publish date: October 19, 2016
Photo from Penn Medicine
NEW YORK—Trial data on the use of chimeric antigen receptor (CAR) T cells in chronic lymphocytic leukemia (CLL) are maturi...
News Author: Erilyn Riley Publish date: October 11, 2016
NEW YORK—The 11th NCCN Congress: Hematologic Malignancies coincided with the release of the inaugural edition of the NCCN treatment guideline on...
News Author: Erilyn Riley Publish date: October 8, 2016
NEW YORK—Two presentations at the NCCN 11th Annual Congress: Hematologic Malignancies addressed the importance of supportive care in the ...
News Author: Erilyn Riley Publish date: October 7, 2016
NEW YORK—The importance of cell of origin in choosing a treatment for diffuse large B-cell lymphoma (DLBCL) is a topic “that has been kick...
